Nanopharmaceutics: Part I-Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU

• Egile Nagusiak: Eliana B. Souto (Egilea), Gabriela F. Silva (Egilea), João Dias-Ferreira (Egilea), Aleksandra Zielinska (Egilea), Fátima Ventura (Egilea), Alessandra Durazzo (Egilea), Massimo Lucarini (Egilea), Ettore Novellino (Egilea), Antonello Santini (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2020-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The latest advances in pharmaceutical technology are leading to the development of cutting edged approaches to produce what is now known as the “Holy Grail” of medicine—nanopharmaceutics. Over the latest decade, the pharmaceutical industry has made important contributions to the scale up of these ne...